FXP:NYE-ProShares UltraShort FTSE China 50 (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 15.23

Change

-2.54 (-14.29)%

Market Cap

N/A

Volume

0.53M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

N/A

USD 1.12B
SOXS Direxion Daily Semiconductor B..

-0.95 (-4.33%)

USD 0.85B
PSQ ProShares Short QQQ

-0.04 (-0.10%)

USD 0.58B
SPXU ProShares UltraPro Short S&P50..

-0.01 (-0.04%)

USD 0.54B
SDOW ProShares UltraPro Short Dow30

-0.04 (-0.30%)

USD 0.31B
DOG ProShares Short Dow30

-0.01 (-0.04%)

USD 0.16B
SPDN Direxion Daily S&P 500® Bear ..

-0.01 (-0.09%)

USD 0.16B
RWM ProShares Short Russell2000

+0.02 (+0.10%)

USD 0.15B
DUST Direxion Daily Gold Miners Ind..

+0.02 (+0.39%)

USD 0.12B
FNGD MicroSectors FANG+ Index -3X I..

-0.39 (-1.70%)

USD 0.11B

ETFs Containing FXP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -61.12% 9% A- 2% F
Dividend Return 1.54% 4% F 31% F
Total Return -59.58% 9% A- 2% F
Trailing 12 Months  
Capital Gain -59.38% 23% F 2% F
Dividend Return 2.45% 23% F 34% F
Total Return -56.92% 21% F 3% F
Trailing 5 Years  
Capital Gain -77.17% 62% D 4% F
Dividend Return 2.39% 58% F 7% C-
Total Return -74.78% 62% D 4% F
Average Annual (5 Year Horizon)  
Capital Gain 54.37% N/A N/A 95% A
Dividend Return 55.01% N/A N/A 95% A
Total Return 0.65% N/A N/A 16% F
Risk Return Profile  
Volatility (Standard Deviation) 660.74% N/A N/A 2% F
Risk Adjusted Return 8.33% N/A N/A 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike